Business Briefing: Medtronic Chief Defends Deal for Irish Company

Posted by Unknown on Tuesday, August 19, 2014


HTTP/1.1 302 Found Date: Wed, 20 Aug 2014 02:36:04 GMT Server: Apache Set-Cookie: NYT-S=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; path=/; domain=www.stg.nytimes.com Set-Cookie: NYT-S=0My.qIcLi.O3XDXrmvxADeHCBQXnW.6zQKdeFz9JchiAIUFL2BEX5FWcV.Ynx4rkFI; expires=Fri, 19-Sep-2014 02:36:04 GMT; path=/; domain=.nytimes.com Location: http://www.nytimes.com/2014/08/20/business/medtronic-chief-defends-deal-for-irish-company.html?partner=rss&emc=rss&_r=0 Content-Length: 0 Cneonction: close Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Server: Apache Cache-Control: no-cache Content-Type: text/html; charset=utf-8 Transfer-Encoding: chunked Date: Wed, 20 Aug 2014 02:36:04 GMT X-Varnish: 2074812815 2074805181 Age: 102 Via: 1.1 varnish X-Cache: HIT X-API-Version: 5-5 X-PageType: article Connection: close 002009








http://nyti.ms/1mjOW9X
See next articlesSee previous articles























Continue reading the main storyShare This Page


Medtronic’s chief executive, Omar Ishrak, defended his company’s $42.9 billion plan to acquire Dublin-based Covidien in a so-called inversion deal, saying the medical device maker will be able to create more jobs in the United States while still paying substantial taxes once the transaction closes. Mr. Ishrak, in remarks on Tuesday during the company’s earnings conference call, said Medtronic expected to invest “much more aggressively” in the United States after the deal closed. Net earnings fell to $871 million, or 87 cents a share, in the first quarter ended July 25, from $953 million, or 93 cents a share, a year earlier. Excluding restructuring charges and costs related to the Covidien acquisition, Medtronic earned 93 cents a share. Analysts on average expected 92 cents, according to Thomson Reuters.



More on nytimes.com


Site Index





0





more

{ 0 comments... » Business Briefing: Medtronic Chief Defends Deal for Irish Company read them below or add one }

Post a Comment

Popularne posty